Literature DB >> 1393560

Age-related changes in kynurenic acid production in rat brain.

J B Gramsbergen1, W Schmidt, W A Turski, R Schwarcz.   

Abstract

Two separate in vitro assays were used to examine the biosynthesis of the broad spectrum excitatory amino acid receptor antagonist kynurenic acid (KYNA) during the life span of the adult rat. Assessment of KYNA's anabolic enzyme kynurenine aminotransferase revealed steady increases between 3 and 24 months of age in all five brain regions examined. No changes were observed in the liver. The changes were particularly pronounced in the cortex and in the striatum where enzyme activity increased three-fold during the period studied. KYNA production from its bioprecursor L-kynurenine was also investigated in tissue slices and was found to be significantly enhanced in the cortex and hippocampus of old animals. The effect of depolarizing agents or sodium replacement was virtually identical in tissues from young and old rats. These data, which are in excellent agreement with reports on an age-dependent increase of KYNA concentration in brain tissue, suggest an enhanced KYNA tone in the aged brain. Together with the reported decline in cerebral excitatory amino acid receptor densities with age, increased production of KYNA may play a role in cognitive and memory dysfunction in old animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393560     DOI: 10.1016/0006-8993(92)91337-e

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.

Authors:  Airi Sekine; Yusuke Kuroki; Tomomi Urata; Noriyuki Mori; Tsutomu Fukuwatari
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

2.  Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.

Authors:  Gregory Oxenkrug
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

3.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

4.  Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Sara K Olsson; Martin Samuelsson; Peter Saetre; Leif Lindström; Erik G Jönsson; Conny Nordin; Göran Engberg; Sophie Erhardt; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2010-05       Impact factor: 6.186

5.  Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism.

Authors:  Gregory F Oxenkrug; Valeria Navrotskaya; Lyudmila Voroboyva; Paul Summergrad
Journal:  Fly (Austin)       Date:  2011-10-01       Impact factor: 2.160

Review 6.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2009-11-26       Impact factor: 3.575

8.  Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Howard Robinson; Jianyong Li
Journal:  Biosci Rep       Date:  2008-08       Impact factor: 3.840

9.  Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.

Authors:  Ping Yu; Nicholas A Di Prospero; Michael T Sapko; Tao Cai; Amy Chen; Miguel Melendez-Ferro; Fu Du; William O Whetsell; Paolo Guidetti; Robert Schwarcz; Danilo A Tagle
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).

Authors:  N Galeotti; C Ghelardini; A Pittaluga; A M Pugliese; A Bartolini; D Manetti; M N Romanelli; F Gualtieri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.